Ebola vaccines help in preventing infection from one of the five identified Ebola virus species, which cause severe hemorrhagic fever in humans and nonhuman primates. Different Ebola vaccines are being developed that can help in controlling outbreaks and protecting at-risk populations such as healthcare workers and laboratory staff. The global Ebola vaccine market comprises products in...
The Ebola vaccine market has seen considerable growth over the past few years owing to the spread of the disease in Africa and the need to curb future outbreaks. Ebola vaccines help stimulate the production of antibodies that fight against the Ebola virus when infected, thereby preventing or reducing the severity of the disease. Manufacturers are developing vaccines using new technologies like...
The Ebola vaccine market is estimated to be valued at US$ 5.83 Bn in 2023 and is expected to exhibit a CAGR of 32% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Ebola vaccine market consists of vaccines that provide protection against Ebola virus infection. Ebola virus causes a severe hemorrhagic fever in humans...